August 2018 Find out more about: Member Spotlight – HepatoChem Summer Interns Present Accomplishments NSIV Companies Making News Other News of Interest
Once again, interns working at NSIV impressed us with all they accomplished, both for their companies and personally. At the August InnoVentures U, our summer interns made formal presentations before a group of 30, explaining
HepatoChem was founded as a company for metabolite production, hence the name — “Hepato” refers to the liver, which is the organ responsible for most of metabolism. The company provides a sort “chemical liver” for
July 2018 Find out more about: Getting to Know CEO Chris Ilsley Member Spotlight – Glycologix Five Words – Our Companies Do What? Around the World with NSIV Read the newsletter in your browser or open it as
New NSIV CEO & President, Chris Ilsley (say “ills lee”) has been with us for just over a month. We briefly introduced him to you in last month’s newsletter, but now it’s time for a
This month, we welcome back Glycologix, who recently rejoined NSIV. At Glycologix, what began as a potential cure for wrinkles has evolved into what could become the first treatment on the market for a debilitating
NSIV member company, InsomniSolv, recently won Sanofi’s VivaTech 2018 “Sleep Challenge”, voted the winner over 21 other submissions. Founder, Peter Kelley, is developing a neurostimulator device to mitigate insomnia. Read about the “Sleep Challenge” and
June 2018 Find out more about: Welcome to New NSIV President & CEO Member Spotlight – Genomic Expression New Companies Join NSIV Summer Interns are Here! The World Cup Read the newsletter in your browser or open
Every year, $100 billion goes into standard cancer treatment, prescribed based on the cancer’s stage and tissue of origin. Patients receiving these treatments assume that they are being given the medicine they need, but the
On June 18, 2018, the North Shore InnoVentures board announced the appointment of Chris Ilsley as CEO and President. Ilsley replaces outgoing CEO Martha Farmer who has overseen a decade of growth for the biotech and
May 2018 Find out more about: NSIV is turning 10! Cummings Foundation Awards Ceremony Member Spotlight – CrowdComfort NSIV Spring ’18 Interns Newest Lab Equipment Read the newsletter in your browser or open it as a PDF.
CrowdComfort CrowdComfort started as a simple idea, pitched at the 2013 Boston Cleanweb Hackathon: what if people could use their smartphones to unlock efficiencies in building and workplace management? Since these humble beginnings, CrowdComfort has
April 2018 Find out more about: NSIV Wins Technology Incubator of the Year NSIV Awarded 10-Year Sustaining Grant from Cummings Foundation Member Spotlight – Akita Innovations Sad News from NSIV Headquarters Read the newsletter in your browser or open
Akita Innovations custom synthesizes novel materials and chemicals. Akita develops and sells high-value materials for companies that want an edge on their competitors and government customers who have unique and demanding requirements. Its chemicals and materials
NSIV is thrilled to share the wonderful news that we are receiving a grant from the Cummings Foundation’s new Sustaining Grants Program. The grant will provide NSIV with an annual installment of $20,000 for ten years.
NSIV has won the “Dinah Adkins Technology Incubator of the Year” award presented on April 23rd at the InBIA’s 32nd International Conference on Business Incubation, held in Dallas. Naturally, Marty and Tom were on hand
March 2018 Find out more about: Newest Member – Inovotion Member Spotlight – Adeptrix Siris Medical Graduates What’s Happening at NSIV? Read the newsletter in your browser or open it as a PDF.
Adeptrix is creating a microarray research tool for targeted proteomics that employs both affinity enrichment of proteins with mass spectrometry for efficient and sensitive measurement of multiple biomarkers in a single experiment. The BAMS (Bead-Assisted
iHope Network, a member of North Shore InnoVentures, was recently featured on The NAMI Radio Hour. Tom Hunter, CEO, joined host Jeff Fladen, Executive Director of NAMI Tennessee to discuss telemedicine and its use in
Interested in incubating your company with NSIV? Submit your application today!